Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - roger greenberg

1 Results Sort By:
Novel class of therapeutics for treatment of lupus and other autoimmune and inflammatory conditions
First in class compounds inhibiting BRISC deubiquitinating enzymes for treatment of autoimmune diseases. Problem: Lupus is an autoimmune disease affecting approximately 5 million people worldwide. Lupus results in a hyperactive immune system and multisystem pathologic changes to joints, skin, kidneys, blood cells, and lungs. Immunosuppressive...
Published: 2/4/2020   |   Inventor(s): Roger Greenberg
Keywords(s):  
Category(s): Therapeutics & Vaccines